Allspring Global Investments
CABA icon

Allspring Global Investments’s Cabaletta Bio CABA Stock Holding History

Allspring Global Investments’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,164
Closed -$26.4K – 2313
2023
Q4 		$26.4K Sell
1,164
-2,972
-72% -$50K ﹤0.01% 1951
2023
Q3 		$62.9K Buy
+4,136
New +$56.5K ﹤0.01% 2184
2022
Q2 		– Sell
-21,381
Closed -$43K – 2717
2022
Q1 		$43K Sell
21,381
-269
-1% -$703 ﹤0.01% 2861
2021
Q4 		$82K Buy
+21,650
New +$231K ﹤0.01% 2793

Other funds holding CABA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Allspring Global Investments's CABA Position: Q1 2024 in Review

Allspring Global Investments sold out of Cabaletta Bio (CABA) in Q1 2024, closing a stake of 1,164 shares — an estimated $26.4K sold.

Allspring Global Investments first reported a position in CABA in Q4 2021 and held it in 4 quarters. The position peaked at $82K in Q4 2021. 159 funds tracked by Wall St. Rank hold CABA as of Q1 2024.

  • Allspring Global Investments reported no remaining Cabaletta Bio position as of Q1 2024 after selling out during the quarter.
  • Allspring Global Investments sold 1,164 Cabaletta Bio shares in Q1 2024, an estimated $26.4K.
  • Allspring Global Investments first reported a position in Cabaletta Bio in Q4 2021 and held it in 4 quarters.
  • Allspring Global Investments's Cabaletta Bio position peaked at $82K in Q4 2021.
  • 159 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2024.

Based on Allspring Global Investments's 13F filing for Q1 2024, filed 18 Apr 2024.